Sequencing Reagents Market Players:
- Thermo Fisher Scientific, Inc.
- Company Overview
- Business Planning
- Main Product Offerings
- Financial Execution
- Main Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Illumina, Inc.
- QIAGEN
- BGI
- Pacific Biosciences of California, Inc.
- F. Hoffmann-La Roche A.G.
- Oxford Nanopore Technologies
- Agilent Technologies, Inc.
- Fluidigm Corporation
- ArcherDX, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of sequencing reagents is assessed at USD 10.62 billion.
The global sequencing reagents market size was valued at over USD 9.73 billion in 2025 and is expected to expand at a CAGR of over 10.2%, surpassing USD 25.7 billion revenue by 2035.
North America sequencing reagents market achieves a 34% share by 2035, fueled by the region’s advanced healthcare system and leadership in medical innovations.
Key players in the market include Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN, BGI, Pacific Biosciences of California, Inc., F. Hoffmann-La Roche A.G., Oxford Nanopore Technologies, Agilent Technologies, Inc., Fluidigm Corporation, ArcherDX, Inc., Myriad Genetics. Inc., Eurofins Scientific, Takara Bio Inc., Mitsui Information Co., Ltd.
